Livrare gratuită pentru comenzile peste 349,00 lei.

Verifică starea comenzii

Faceți parte dintr-o comunitate de iubitori de cărți din întreaga lume și beneficiați de o mulțime de avantaje Creați-vă un cont gratuit

Transport gratuit la punctele de livrare Pick Up peste 349.00 lei

Packeta 15.00 lei Cargus 28.00 lei Easybox 20.00 lei FAN 20.00 lei Punct FAN 16.00 lei Punct DPD 17.00 lei Curier Sameday 24.00 lei Curier DPD 25.00 lei

Contact

Cum să cumpăr

Ajutor

Contul meu

▸ Gol :-(

Livrare gratuită pentru comenzile peste 349,00 lei.

Psychedelic Harm Reduction

Name: Psychedelic Harm Reduction
Brand: Springer, Berlin
SKU: 51248624
Price: 964.75 RON
Availability: InStock
Author: Tomislav Majic
ISBN: 9783032211064

DE

Tomislav Majic

Limba

engleză

Carte Copertă tare

Codul Libristo: 51248624

Editura Springer, Berlin, iulie 2026

Scientific interest in classic psychedelics such as psilocybin, LSD, and 5-MeO-DMT has resurged, wit... Descrierea completă

Codul Libristo: 51248624

446 b

Nou

964.75 lei

În depozitul extern Expediem în 10-13 zile

30 de zile pentru retur bunuri

Clienții au cumpărat de asemenea

Prüfung Express - Goethe Zertifikat C1, Deutschprüfung für Erwachsene Christine Kramel

Carte

74.36 lei

Manuel de laboratoire sur les moteurs ? combustion interne Mohammad Ali Shariati

Carte broșată

246.58 lei

Python 3 et Machine Learning - Coffret de 2 livres : Théorie et pratique (2e édition) CHAZALLET

Carte broșată

482.37 lei

Purées ou morceaux ? Loubet

Copertă tare

89.32 lei

Die geilste Lücke im Lebenslauf Nick Martin

Carte broșată

70.31 lei

Scientific interest in classic psychedelics such as psilocybin, LSD, and 5-MeO-DMT has resurged, with promising results for the treatment of mental health conditions including depression, anxiety, and substance use disorders. At the same time, public interest in those substances has increased, giving rise to what has been labelled as a "psychedelic renaissance". Although it has been repeatedly emphasized that psychedelics are not addictive and exhibit very low toxicity, their use is nevertheless associated a range of rare, but considerable risks and potential harms which may even occur after sporadic use. To date, these risks to date remain underrecognized and underresearched, and many clinical psychiatrists and psychologist are insufficiently informed about their pathophysiology, differential diagnosis and clinical management. This book addresses this gap by providing health care professionals and researchers with foundational information on the diverse risks and adverse effects associated with the use of classic psychedelics.

The chapter "Classifying Psychedelic-Related Complications" is available open access under the Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International License via link.springer.com.